In this edition Also - Eurosurveillance

More documents

Recommendations

Info

Special issue: European Immunization Week 2008 - time for reflection Surveillance and outbreak reports M e a s l e s and M u M p s i M M u n i t y in no r t h e r n Gr e e c e , 2004-2007 A Fylaktou 1 , K Haidopoulou 2 , M Goutaki 2 , E Papadimitriou 1 , S Kalamitsiou 2 , D Papaventsis (dpapaventsis@yahoo.gr) 1 1. Laboratory of Microbiology, General Hospital Papageorgiou of Thessaloniki, Greece 2. Fourth Paediatric Department, Medical School, Aristotle University of Thessaloniki, Greece A cross-sectional study was conducted in order to determine the prevalence of mumps and measles antibodies in a representative sample of the general population in Northern Greece between January 2004 and May 2007. Overall, 900 healthy individuals participated in the study. The great majority were found to be protected against measles. The total protection rate against mumps was significantly less (87% versus 72%, respectively; p
Statistical analysis The antibody prevalence was calculated for both sex and age groups. The chi square test was used to compare proportions. The Fisher’s exact test was applied when the expected frequencies were below five. All calculations were carried out using SPSS version 14.00 (SPSS, Chicago, IL, USA). Results Overall, 900 healthy individuals participated in the study. The age-stratified population consisted of 428 males and 472 females (48% and 52%, respectively). The demographic distribution of each study group was similar to that of the entire northern Greek population. <strong>In</strong> particular, 6% of the tested individuals were younger than six months old, 6% were 0.5 to 1.5 years-old, 6% were 1.5 to 5, 6% were 5 to 11, 12% were 11 to 20, 14% were 21 to 30, Table 1 Mumps and measles seroprevalence, Northern Greece, January 2004 - May 2007 Age Groups No. Tested 14% were 31 to 40, 14% were 41 to 50, 12% were 51 to 60, and 10% were 60 years-old (>1/10,000 representation in all age groups, except for the age group over 60 years). A total of 900 serum samples, collected during the study period, were analysed. The population distribution, according to age and sex, and the seroprevalence results are presented in Table 1. The majority of our study population was found to be protected against measles (87%). Although most individuals were protected against mumps, too, the total protection rate against mumps was significantly lower (72%) (p
Page 1 and 2: EUROPEAN CENTRE FOR DISEASE PREVENT
Page 3 and 4: Special issue: World Hepatitis Day
Page 5 and 6: oth measles and mumps in certain ag
Page 7 and 8: to be done. Twenty-nine of the 53 c
Page 9 and 10: Editorial W o r l d He pat i t i s
Page 11 and 12: Editorials M o l e c u l a r t y p
Page 13: 5. Fooks A. Rabies remains a ‘neg
Page 17 and 18: mumps that we noticed between males
Page 19 and 20: Among the cases, 3,683 (61.8%) were
Page 21 and 22: [5] Given the periodicity of outbre
Page 23 and 24: sequences (GenBank NIH, Bethesda) p
Page 25 and 26: Special issue: European Immunizatio
Page 31 and 32: No. of reported rubella cases Speci
Page 33 and 34: Special issue: Molecular typing for
Page 35 and 36: From these discussions, and by test
Page 37 and 38: 15. Hæggman S, Rhod Larsen A, Vain
Page 39 and 40: Table 1 SeqNet.org participating me
Page 41 and 42: first line typing method, besides o
Page 45 and 46: criteria are combined, (iii) the or
Page 47 and 48: Retrospective surveillance data fro
Page 53 and 54: Special Issue: World Hepatitis Day
Page 55 and 56: Table Number of notifications of he
Page 57 and 58: 5. Hoffmann G, Berglund G, Elmståh
Page 59 and 60: Our epidemiological and molecular i
Page 61 and 62: The questionnaire was structured ac
Page 63 and 64: Table 2 HIV and hepatitis C testing
Page 65 and 66:
to be paid regarding HCV. The repor
Page 67 and 68:
Table 1 Summary of hepatitis B surv
Page 69 and 70:
of the different genotypes vary bot
Page 71 and 72:
Figure The incidence of reported he
Page 73 and 74:
33. Veldhuijzen IK, Smits LJ, van d
Page 75 and 76:
Figure 1 The natural history of HCV
Page 77 and 78:
successful engagement with and trea
Page 79 and 80:
Table 1 Definitions of HCV infectio
Page 81 and 82:
not available for surveillance purp
Page 83 and 84:
Special Issue: World Hepatitis Day
Page 85 and 86:
Surveillance and outbreak reports E
Page 87 and 88:
Distributed information about the e
Page 89 and 90:
Surveillance and outbreak reports A
Page 91 and 92:
Table 1 Survey data regarding surve
Page 93 and 94:
For the presented period of the pas
Page 95 and 96:
or individuals who acquired the inf
Page 97 and 98:
Surveillance and outbreak reports A
Page 99 and 100:
analysable fragment of 457 bp, and
Page 101 and 102:
the application of HNIG to close co
Page 103 and 104:
HCV co-infection was defined as pos
Page 105 and 106:
[18] had been observed in HIV-HBV c
Page 107 and 108:
Microbiological investigation All h
Page 109 and 110:
References 1. American Public Healt
Page 111 and 112:
Telephone calls are handled by a tw
Page 113 and 114:
At that time, the daily monitoring
Page 115 and 116:
Research articles S u r v e i l l a
Page 117 and 118:
It has been suggested that longer d
Page 119 and 120:
Virological data collection Stool s
Page 121 and 122:
Discussion Our combined epidemiolog
Page 123 and 124:
Acknowledgements We are grateful to
Page 125 and 126:
The total study sample consisted of
Page 127 and 128:
Table Multivariate model of associa
Page 129 and 130:
Euroroundups S u r v e y o f eu r o
Page 131 and 132:
event. The survey included question
Page 133 and 134:
Laboratories report anonymised case
Page 135 and 136:
8. European Union. Commission decis
Page 137 and 138:
two females aged six years and 56 y
Page 139 and 140:
Table 2 Salmonella infections with
Page 141 and 142:
17. The Community Summary Report on
Page 143 and 144:
the number of registered cases in E
Page 145 and 146:
protected vaccinees annually) [6].
Page 147 and 148:
Romania Risk of tick-borne encephal
Page 149 and 150:
34. Pavlidou V, Geroy S, Diza E, An
Page 151 and 152:
European Commission and the EU Memb
Page 153 and 154:
10. Strauss R, Muchl R, Kunze M, Hr
Page 155 and 156:
Existing monitoring efforts in Euro
Page 157 and 158:
with existing efforts in influenza
Page 159 and 160:
Obtaining a true picture of the bur
Page 161 and 162:
of being too clean, concerns about
Page 163 and 164:
single case of the disease while in
Page 165 and 166:
Rapid communications E m E rg E n c
Page 167 and 168:
Development and Food. More specific
Page 169 and 170:
Rapid communications I n c r e a s
Page 171 and 172:
immunity was high enough to prevent
Page 173 and 174:
Control measures Information about
Page 175 and 176:
• The importance of ensuring that
Page 177 and 178:
Letters A u t h o r s r e p ly : pr
Page 179 and 180:
UNITED KINGDOM England and Wales He
show all

In this edition Also - Eurosurveillance

Create successful ePaper yourself

Delete template?

Save as template?